We are providing preclinical in vivo and in vitro models with focus on autoimmunity and inflammatory conditions. We offer customized, high quality services spanning all aspects of the preclinical phase of the project including Mechanism of Action (MoA) evaluation, ex vivo ranking, Pharmacokinetic (PK) investigation, biomarker identification, in vivo efficacy and biomarker analyses.
By using Redoxis as your service provider you will get:
- High quality studies
- Dedicated personnel with expertise in the field and many years of experience designing studies and interpreting data.
- A committed contact person responsible for your study facilitating communication.
- Flexibility in study design and agility to reduce lead time from decision to execution